No strict or extreme diet is required
Olympic Trials and multiple World Marathon Majors.
(4) Clinical combinations: BBR-silymarin co-administration significantly improves glycemic control (fasting glucose, HOMA-IR) and lipid profiles (TG, LDL) in diabetic patients, and decreases BMI, and the WHR in obesity patients versus BBR monotherapy [196]
Our team thoroughly assesses patients before writing an Ozempic prescription to make sure they dont have any contraindications, such as a history of medullary thyroid cancer, multiple endocrine neoplasia syndrome type 2, or an allergy to the medications key ingredient, Semaglutide GLP-1
Refer to physical therapists or trainers when needed
Monitoring considerations: HbA1c and fasting glucose (for T2DM patients) at 3-month intervals